UM

Browse/Search Results:  1-10 of 63 Help

Selected(0)Clear Items/Page:    Sort:
Anti-inflammatory activity of flavonols via inhibiting MAPK and NF-κB signaling pathways in RAW264.7 macrophages Journal article
Current Research in Food Science, 2022,Volume: 5,Issue: 2022
Authors:  RutingZhong;  Lingchao Miao;  Haolin Zhang;  Lihua Tan;  Yuxin Zhao;  Yanbei Tu;  Miguel Angel Priet;  Jesus Simal-Gandara;  Lei Chen;  Chengwei He;  Hui Cao
Adobe PDF | Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/08/03
Fisetin  Quercetin  Myricetin  Anti-inflammation  Nf-κb  Mapk  
A multi-omics analysis for prediction of neurocognitive disorders risk among the elderly in Macao. Clinical and Translational Medicine Journal article
Clinical and Translational Medicine, 2022,Volume: 12,Page: e909
Authors:  Yan Han;  Xingping Quan;  Yaochen Chuang;  Qiaoxing Liang;  Yang Li;  Zhen Yuan;  Ying Bian;  Lai Wei;  JiWang;  Yonghua Zhao
Adobe PDF | Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/07/29
Exosomes  Gut Microbiota  Multi-omics  Neurocognitive Disorders  
Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin Journal article
eFood, 2022,Volume: 3,Issue: e3
Authors:  Ruting ZHONG;  Mohamed A. Farag;  Meiwan Che;  Chengwei He;  Jianbo Xiao
Adobe PDF | Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/07/29
Bioactivities  Fisetin  Molecular Mechanism  Pharmacokinetics  Structure–activity Relationship  
Buxue Yimu Pills improve angiogenesis and blood flow in experimental zebrafish and rat models Journal article
Journal of Ethnopharmacology, 2022,Volume: 289
Authors:  Zhang, Le Le;  Sheng, Feiya;  He, Yan;  Yang, Yong;  Hu, Ying Fan;  Li, Wei;  Li, Peng;  Wu, Meng Yao;  Gong, Yun;  Zhang, Yamei;  Zou, Liang
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/05/13
Angiogenesis  Blood Flow  Buxue Yimu Pills  Medical Abortion Rats  Zebrafish  
2-Methoxy-6-acetyl-7-methyljuglone (MAM) Activated Necroptosis as A New Therapeutic Avenue for Non-Small Cell Lung Cancer Resistant to EGFR Tyrosine Kinase Inhibitor Osimertinib Project
项目编号: MYRG2020-00053-ICMS, 2022-
Authors:  XPCHEN
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/02/16
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy Journal article
Journal of Cancer Research and Clinical Oncology, 2021,Volume: 147,Issue: 12,Page: 3653-3664
Authors:  Zhao, Yuxin;  Wang, Haiyong;  He, Chengwei
Favorite |  | TC[WOS]:7 TC[Scopus]:7 | Submit date:2021/12/08
Drug Resistance  Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor  Non-small Cell Lung Cancer  Targeted Therapy  
Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy Journal article
Advanced Science, 2021,Volume: 8,Issue: 21
Authors:  Lei, Josh Haipeng;  Lee, Mi Hye;  Miao, Kai;  Huang, Zebin;  Yao, Zhicheng;  Zhang, Aiping;  Xu, Jun;  Zhao, Ming;  Huang, Zenan;  Zhang, Xin;  Chen, Si;  Jiaying, N. G.;  Feng, Yuzhao;  Xing, Fuqiang;  Chen, Ping;  Sun, Heng;  Chen, Qiang;  Xiang, Tingxiu;  Chen, Lin;  Xu, Xiaoling;  Deng, Chu Xia
Favorite |  | TC[WOS]:2 TC[Scopus]:1 | Submit date:2021/11/30
Brca1  Breast Cancer  Fgfr2 Inhibitor  Fgfr2-s252w  Tumor Slice Culture  
Berberine and Momordin Ic regulate autophagy with opposite effects on the activity of anticancer agents Thesis
Macau: University of Macau, 2021
Authors:  Han, B;  He, C. W.
Favorite |  | Submit date:2022/07/28
Autophagy  Natural Compounds  Breast Cancer  Nsclc  Resistance  Egfr Tki  
Expansion of Rare Cancer Cells into Tumoroids for Therapeutic Regimen and Cancer Therapy Journal article
Advanced Therapeutics, 2021,Volume: 4,Issue: 7
Authors:  Enkhbat, Myagmartsend;  Liu, Yung Chiang;  Kim, Jua;  Xu, Yanshan;  Yin, Zongyi;  Liu, Tzu Ming;  Deng, Chu Xia;  Zou, Chang;  Xie, Xi;  Li, Xiaowu;  Wang, Peng Yuan
Adobe PDF | Favorite |  | TC[WOS]:1 TC[Scopus]:1 | Submit date:2021/12/08
Assembloid  Cancer Stem Cell  Circulating Tumor Cell  Drug Screening  Microenvironment  
Engineered exosomes: Desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies Journal article
Theranostics, 2021,Volume: 11,Issue: 18,Page: 8926-8944
Authors:  Xu, Meng;  Feng, Tao;  Liu, Bowen;  Qiu, Fen;  Xu, Youhua;  Zhao, Yonghua;  Zheng, Ying
Adobe PDF | Favorite |  | TC[WOS]:16 TC[Scopus]:17 | Submit date:2022/05/13
Administration Routes  Brain Targeting  Cerebrovascular Disease  Engineered Exosomes  Neurological Disorders  Tracking